Carlsmed, Inc. CARL
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.25M | -10.51M | -8.70M | -8.61M | -8.53M |
| Total Depreciation and Amortization | 126.00K | 130.00K | 99.00K | 98.00K | 82.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.32M | 3.75M | 2.78M | 1.54M | 1.49M |
| Change in Net Operating Assets | -871.00K | -732.00K | -7.19M | 1.65M | -1.50M |
| Cash from Operations | -8.67M | -7.36M | -13.01M | -5.32M | -8.46M |
| Capital Expenditure | -283.00K | -121.00K | -79.00K | -73.00K | -159.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.51M | -19.54M | -127.00K | -24.16M | -184.00K |
| Cash from Investing | -1.80M | -19.66M | -206.00K | -24.23M | -343.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 367.00K | 243.00K | 436.00K | 21.00K | 93.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -195.00K | -- | -- | -50.00K | -2.76M |
| Cash from Financing | 172.00K | 243.00K | 436.00K | -29.00K | 90.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.30M | -26.77M | -12.78M | -29.58M | 81.90M |